⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
globenewswire.com
GMAB
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
businesswire.com
GMAB
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
globenewswire.com
GMAB
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
globenewswire.com
GMAB
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
businesswire.com
JNJ
GMAB
Tissue Factor-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality
globenewswire.com
PFE
GMAB
IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays, Upcoming Webinar Hosted by Xtalks
prnewswire.com
JAZZ
GMAB
Capital Increase in Genmab as a Result of Employee Warrant Exercise
globenewswire.com
GMAB
Major Shareholder Announcement
globenewswire.com
GMAB